Protalix Biotherapeutics, Inc. (PLX)
2.21
+0.06
(+2.79%)
USD |
NYAM |
Apr 06, 16:00
2.205
0.00 (0.00%)
After-Hours: 20:00
Protalix Biotherapeutics SG&A Expense (TTM) : 11.68M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Agenus, Inc. | 54.39M |
| Lisata Therapeutics, Inc. | 10.43M |
| InspireMD, Inc. | 37.26M |
| Lifeward Ltd. | 22.07M |
| Denali Therapeutics, Inc. | 136.56M |